Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Acerus Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 10
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Trimel Pharma Acquires Canadian Rights to Estrace from Shire for USD41.3 Million 13
Partnerships 15
Trimel Pharma Enters Into Co-Development Agreement With European Company 15
Licensing Agreements 16
Acerus Pharma Enters into Licensing Agreement with Pharmanest 16
Producto Cientificos Enters into Licensing Agreement with Acerus Pharma 17
Acerus Pharma Enters into Distributor and Licensing Agreement with Metuchen Pharma 18
Acerus Pharma Enters into Licensing Agreement with Viramal 19
Apsen Farmaceutica Enters into Licensing Agreement with Acerus Pharma 20
Eu Hwa Enters into Licensing Agreement with Acerus Pharma for NATESTO 21
medac Enters into Licensing Agreement with Acerus Pharma for NATESTO 22
Therios Healthcare Enters into Licensing Agreement with Acerus Pharma for NATESTO 23
Aytu BioScience Enters into Licensing Agreement with Acerus Pharma 24
Acerus Pharma Enters into Licensing Agreement with Medinova 25
Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma 26
Equity Offering 27
Acerus Pharma Raises USD5.1 Million in Private Placement of Units 27
Acerus Pharma Raises USD2 Million in Private Placement of Shares 29
Trimel Pharma Raises USD16.6 Million in Private Placement of Shares 30
Acerus Pharma Raises USD2.1 Million in Private Placement of Shares 31
Trimel Pharma Announces Full Exercise Of Underwriter’s Option For Public Offering Of Shares For US$45 Million 32
Trimel Pharma Announces Rights Offering Of Shares 34
Trimel Pharma Completes Public Offering Of Units For US$13 Million 35
Debt Offering 37
Trimel Pharma Raises USD25 Million in Private Placement of 9.5% Convetible Note Due 2015 37
Acerus Pharmaceuticals Corp – Key Competitors 38
Acerus Pharmaceuticals Corp – Key Employees 39
Acerus Pharmaceuticals Corp – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Financial Announcements 41
Aug 13, 2018: Acerus Reports second quarter 2018 financial results 41
May 15, 2018: Acerus Reports First Quarter 2018 Financial Results 44
Nov 07, 2017: Acerus Reports Third Quarter 2017 Financial Results 46
Aug 11, 2017: Acerus Reports Second Quarter 2017 Financial Results 48
Mar 08, 2017: Acerus Reports Fourth Quarter and Full Year 2016 Financial Results 50
Corporate Communications 52
Jun 05, 2018: Acerus Announces Resignation Of Luc Mainville As Director 52
Mar 29, 2018: Acerus Announces Executive Leadership Change 53
Dec 07, 2017: Acerus Appoints Mr. Mark Lievonen to its Board of Directors 54
Oct 02, 2017: Acerus Announces Executive Leadership Change 55
May 05, 2017: Acerus Announces Appointment of Ken Yoon as Chief Financial Officer 56
Legal and Regulatory 57
Apr 10, 2018: Acerus Announces Settlement of Melnyk Litigation 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Acerus Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Acerus Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 10
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Trimel Pharma Acquires Canadian Rights to Estrace from Shire for USD41.3 Million 13
Trimel Pharma Enters Into Co-Development Agreement With European Company 15
Acerus Pharma Enters into Licensing Agreement with Pharmanest 16
Producto Cientificos Enters into Licensing Agreement with Acerus Pharma 17
Acerus Pharma Enters into Distributor and Licensing Agreement with Metuchen Pharma 18
Acerus Pharma Enters into Licensing Agreement with Viramal 19
Apsen Farmaceutica Enters into Licensing Agreement with Acerus Pharma 20
Eu Hwa Enters into Licensing Agreement with Acerus Pharma for NATESTO 21
medac Enters into Licensing Agreement with Acerus Pharma for NATESTO 22
Therios Healthcare Enters into Licensing Agreement with Acerus Pharma for NATESTO 23
Aytu BioScience Enters into Licensing Agreement with Acerus Pharma 24
Acerus Pharma Enters into Licensing Agreement with Medinova 25
Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma 26
Acerus Pharma Raises USD5.1 Million in Private Placement of Units 27
Acerus Pharma Raises USD2 Million in Private Placement of Shares 29
Trimel Pharma Raises USD16.6 Million in Private Placement of Shares 30
Acerus Pharma Raises USD2.1 Million in Private Placement of Shares 31
Trimel Pharma Announces Full Exercise Of Underwriter's Option For Public Offering Of Shares For US$45 Million 32
Trimel Pharma Announces Rights Offering Of Shares 34
Trimel Pharma Completes Public Offering Of Units For US$13 Million 35
Trimel Pharma Raises USD25 Million in Private Placement of 9.5% Convetible Note Due 2015 37
Acerus Pharmaceuticals Corp, Key Competitors 38
Acerus Pharmaceuticals Corp, Key Employees 39
Acerus Pharmaceuticals Corp, Subsidiaries 40
List of Figures
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Acerus Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer